Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,400.00
(
0.65%
)
Dow Jones
50,461.68
(
0.00%
)
Brent Oil
94.05
(
-3.03%
)
Bitcoin
75,699.99
(
-0.19%
)
News Focus
News Focus
Post# of 257644
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: biomaven0 post# 137743

Thursday, 02/23/2012 11:39:25 PM

Thursday, February 23, 2012 11:39:25 PM

Post# of 257644

Why is this a problem?





It's more of an issue for the FDA to consider than a problem.

Long-term safety of a drug that more than likely will be used irresponsibly, considering the nature of the indication, is a factor. I think the drug is worthy of approval all things considered. I'm just playing the devil's advocate after the lopsided vote of the advisory panel.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today